You searched for "invasive"

782 results found

The Optical Suppliers Association joins The Alliance for Healthcare from the Eye

The Optical Suppliers Association (OSA) has joined The Alliance for Healthcare from the Eye, underscoring its commitment to ethical adoption of oculomics and advancing the role of eye health within broader healthcare pathways. OSA will support the efforts of The...

Landmark review of glaucoma treatment and research published by Moorfields-led team

Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.

Artificial intelligence and oculomics: Improving global health

The application of artificial intelligence (AI), and in particular deep learning, to high-resolution ocular imaging has led to many new discoveries, enabling the prediction of multiple different systemic diseases from ocular biomarkers. This emerging field is known as ‘oculomics’ [1]....

Ocular findings in autism

This retrospective study investigated the ocular manifestations of autistic spectrum disorders (ASD) among children in a paediatric ophthalmic practice setting. Fifty-three patients were identified. Assessments were undertaken for 44 with 68% having autistic disorder, 16% with pervasive personality disorder –...

Occult spread of squamous cell carcinoma into the orbit

The authors describe two cases that may represent perineural spread of cutaneous squamous cell carcinoma (SCC) into the orbit. Both cases had cutaneous squamous cell carcinomas in the region of the lateral orbital wall (innervated by the zygomatico-temporal nerve) which...

Insights from the ‘Rb-NET Challenges’ Session: Evolving approaches in global retinoblastoma management

The Retinoblastoma Network (Rb-NET) Multidisciplinary Team (MDT) platform, developed by the London School of Hygiene & Tropical Medicine (LSHTM) and Professor Ido Didi Fabian, is a web-based telemedicine initiative that regularly hosts virtual MDT meetings focused on the evaluation and...

Kabgayi International Ophthalmology Conference 2024

by Michael Mikhail, FRCOphth, Consultant Ophthalmologist; Vitreoretinal Surgeon, Kabgayi Eye Unit, Rwanda. My journey to Rwanda in April 2022 aimed to expand vitreoretinal services, but it also highlighted the need for robust scientific discourse, akin to the UK's ophthalmology culture,...

New Clinical Specialist for the North and National Refractive Specialist

Surgitrac is pleased to announce the appointment of Jessica Seers as Clinical Specialist for the North and National Refractive Specialist for lenses. With a strong clinical background and a passion for ophthalmology, Jessica steps into a dual role that supports...

BBC News Highlights New Approach to Treating Ocular Hypotony

Ocular hypotony has been in the spotlight following recent BBC News coverage highlighting how new clinical research is delivering meaningful benefits for patients affected by this sight threatening condition. The feature draws attention to a newly published study from the...

Orbital rhabdomyosarcoma treatment characteristics

The aim of this study was to review the clinical presentation, management, local and systemic outcomes of 14 orbital rhabdomyosarcoma (OR) cases with the focus on the role of surgery as treatment. The mean age at presentation was eight years...

Microbiology, risk factors and outcomes of microbial keratitis in Sydney, Australia

The authors present a retrospective case series including all patients with microbial keratitis and ocular surface diseases (OSD), including dry eye, blepharitis, Stevens-Johnson syndrome and / or ocular cicatricial pemphigoid, over a five-year period between 2012 and 2016. A total...

Sebaceous gland carcinoma

This is a review of 241 patients diagnosed with periocular sebaceous gland carcinoma which investigates whether age at presentation influences either the clinical presentation or the outcomes of treatment. Twelve percent of patients were classified as young (<40 years old),...